Search results for “organicsynthesis”

#MedicinalChemistry #Organicchemistry #Organicsynthesis

#Europe

Alain Wagner is currently Director (CNRS) of the Laboratory of Functional ChemoSystems (LFCS) at the University of Strasbourg. He obtained his PhD in synthetic chemistry from the University of Strasbo

#organicsynthesis #hplc #massspectrometry

#NorthAmerica

Multi-step organic synthesis, process chemistry, peptide chemistry, palladium mediated cross-coupling, technology transfer and out licensing, drug discovery, structure-based drug design, fragment and

#OrganicSynthesis #OrganicChemistry #Science

#Europe

Andre Cobb Reader in Organic Chemistry at King's College London

#OrganicChemistry #OrganicSynthesis #PharmaceuticalIndustry

#UnitedStates

Andrew Nation is currently working as the Associate Director of Sourcing Excellence R&D at Bristol Myers Squibb, a leading biopharmaceutical company. In this role, he is responsible for driving excell

#organicsynthesis #organicchemistry

#NorthAmerica

Experienced in drug discovery and antibody drug conjugates (ADCs). Former professor of organic chemistry with track record of external funding and publication at a small liberal arts college.

#organicsynthesis #nmrspectroscopy

#NorthAmerica

David Calabrese is a seasoned synthetic organic chemist with a strong foundation in classical training, spanning over 11 years of valuable experience. His expertise extends across diverse realms, enco

#organicsynthesis #organicchemistry #chemistry

#NorthAmerica

Filip Petronijevic is an esteemed Principal Scientist at Bolt Biotherapeutics, a leading company in the field of biotherapeutics and drug development. With an extensive background in scientific resear

#chemistry #organicsynthesis

#Oceania

I lead the CSIRO SME Strategy (SME Collaboration Initiative) which aims to double the number of Australian SMEs (small-medium sized enterprises) that engage with publicy-funded research by 2030.

#organicsynthesis #problemsolving

#NorthAmerica

Highly motivated synthetic organic chemist with experience in methodology development, multistep synthesis and medicinal chemistry research.

#chemistry #polymers #organicsynthesis

#NorthAmerica

PhD in chemistry with extensive experience in reversible deactivation radical polymerization techniques (mechanisms, materials), and small molecule (hypervalent iodine reagents, monomer) synthesis.

#organicsynthesis #drugdiscovery

#NorthAmerica

An accomplished drug discovery leader with experience across several therapeutic areas and target families. Experienced in corporate and portfolio strategy while being driven to create novel medicines

#OrganicSynthesis #NMRSpectroscopy #Chemistry

#NorthAmerica

Ken Lawson is currently a Director of Medicinal Chemistry at Arcus Biosciences where his research has focused on cell intrinsic and immuno-oncology targets. Ken is a synthetic chemist by training. Pri